Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine D3 receptor: basic and clinical aspects

J C Schwartz1, D Levesque, M P Martres

  • 1Unité de Neurobiologie et Pharmacologie (U.109), INSERM, Centre Paul Broca, Paris, France.

Clinical Neuropharmacology
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spontaneous expulsive suprachoroidal hemorrhage following high dose anticoagulation in a highly myopic patient.

Journal francais d'ophtalmologie·2025
Same author

Keep an eye on Neisseria gonorrhoeae.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

[Obstructive hydrocephalus and Crouzon syndrome].

Journal francais d'ophtalmologie·2019
Same author

In the eye of the beholder: Assessing the water quality of shoreline parks around the Island of Montreal through citizen science.

The Science of the total environment·2016
Same author

Inspection of thick welded joints using laser-ultrasonic SAFT.

Ultrasonics·2016
Same author

Liquid-vapor transition and critical behavior of the ultrasoft restricted primitive model of polyelectrolytes: a Monte Carlo study.

The Journal of chemical physics·2014
Same journal

Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

Clinical neuropharmacology·2026
Same journal

Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

Clinical neuropharmacology·2026
Same journal

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Clinical neuropharmacology·2026
Same journal

A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

Clinical neuropharmacology·2026
Same journal

Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

Clinical neuropharmacology·2026
Same journal

Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

Clinical neuropharmacology·2026
See all related articles

The dopamine D3 receptor, a D2-like receptor, is implicated in schizophrenia. Studies suggest a higher risk in individuals with specific D3 receptor gene variations, though further research is needed.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • The dopamine D3 receptor is a recently discovered D2-like receptor.
  • It functions as both an autoreceptor and a postsynaptic receptor, recognized by antipsychotics.
  • Distinct from the D2 receptor, it exhibits discrete expression in limbic areas and higher dopamine affinity.

Purpose of the Study:

  • To explore the characteristics and potential role of the dopamine D3 receptor in neurological conditions.
  • To investigate the association between dopamine D3 receptor gene polymorphism and schizophrenia risk.

Main Methods:

  • Analysis of dopamine D3 receptor gene structure and expression patterns.
  • Review of association studies investigating D3 receptor gene polymorphism and schizophrenia.

Related Experiment Videos

  • Consideration of linkage studies for schizophrenia and D3 receptor genes.

    • Main Results:

    • Dopamine D3 receptor shares characteristics with D2 receptors but has distinct expression and affinity.
    • Preliminary association studies indicate a twofold higher risk of schizophrenia in homozygotes for a D3 receptor gene polymorphism.
    • Linkage studies examining the D3 receptor gene and schizophrenia have yielded inconclusive results.

    Conclusions:

    • The dopamine D3 receptor is a significant target in neuroscience and psychiatry.
    • Evidence suggests a potential link between D3 receptor gene variations and schizophrenia susceptibility.
    • Further comprehensive genetic studies are required to clarify the role of the dopamine D3 receptor in schizophrenia.